Mitsubishi UFJ Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.09B Buy
4,340,720
+309,681
+8% +$66.6M 0.61% 29
2026
Q1
$877M Buy
4,031,039
+278,356
+7% +$61.7M 0.59% 29
2025
Q4
$861M Buy
3,752,683
+183,601
+5% +$41.8M 0.58% 25
2025
Q3
$826M Buy
3,569,082
+154,057
+5% +$31.4M 0.59% 34
2025
Q2
$634M Buy
3,415,025
+224,934
+7% +$41.8M 0.51% 38
2025
Q1
$668M Buy
3,190,091
+341,601
+12% +$66.4M 0.62% 36
2024
Q4
$516M Buy
2,848,490
+242,366
+9% +$44.6M 0.5% 37
2024
Q3
$515M Buy
2,606,124
+190,456
+8% +$35.5M 0.55% 36
2024
Q2
$414M Buy
2,415,668
+259,262
+12% +$42.9M 0.51% 37
2024
Q1
$393M Buy
2,156,406
+311,771
+17% +$53.7M 0.54% 36
2023
Q4
$296M Buy
1,844,635
+107,240
+6% +$15.6M 0.52% 39
2023
Q3
$259M Buy
1,737,395
+132,506
+8% +$19.5M 0.52% 40
2023
Q2
$216M Buy
1,604,889
+76,722
+5% +$11.3M 0.45% 48
2023
Q1
$244M Buy
1,528,167
+140,229
+10% +$21.4M 0.58% 40
2022
Q4
$225M Buy
1,387,938
+151,274
+12% +$23.2M 0.61% 37
2022
Q3
$166M Buy
1,236,664
+131,673
+12% +$18.9M 0.53% 42
2022
Q2
$169M Buy
1,104,991
+77,804
+8% +$11.9M 0.75% 21
2022
Q1
$167M Buy
1,027,187
+68,904
+7% +$10M 0.66% 21
2021
Q4
$130M Buy
958,283
+111,318
+13% +$13.1M 0.52% 33
2021
Q3
$91.4M Buy
846,965
+76,434
+10% +$8.73M 0.45% 41
2021
Q2
$86.8M Buy
770,531
+55,120
+8% +$6.21M 0.47% 37
2021
Q1
$77.4M Buy
715,411
+35,222
+5% +$3.77M 0.51% 38
2020
Q4
$72.9M Buy
680,189
+58,396
+9% +$5.61M 0.56% 33
2020
Q3
$54.5M Buy
621,793
+95,925
+18% +$9.03M 0.5% 41
2020
Q2
$51.6M Buy
525,868
+105,529
+25% +$9.29M 0.59% 35
2020
Q1
$32M Buy
420,339
+74,043
+21% +$6.31M 0.5% 43
2019
Q4
$30.7M Buy
346,296
+79,790
+30% +$6.62M 0.4% 52
2019
Q3
$20.2M Buy
266,506
+10,306
+4% +$707K 0.33% 64
2019
Q2
$18.6M Buy
256,200
+45,695
+22% +$3.59M 0.32% 67
2019
Q1
$17M Buy
210,505
+8,907
+4% +$729K 0.35% 63
2018
Q4
$17.4M Sell
201,598
-12,212
-6% -$1.07M 0.44% 45
2018
Q3
$20.2M Sell
213,810
-4,401
-2% -$417K 0.42% 56
2018
Q2
$20.2M Sell
218,211
-10,605
-5% -$1.04M 0.45% 49
2018
Q1
$21.7M Sell
228,816
-22,737
-9% -$2.5M 0.5% 41
2017
Q4
$25.1M Buy
251,553
+181
+0.1% +$17.1K 0.55% 40
2017
Q3
$22.3M Buy
251,372
+5,438
+2% +$414K 0.53% 44
2017
Q2
$17.8M Sell
245,934
-25,026
-9% -$1.68M 0.44% 53
2017
Q1
$17.7M Buy
270,960
+14,666
+6% +$922K 0.4% 53
2016
Q4
$16M Sell
256,294
-7,758
-3% -$474K 0.39% 60
2016
Q3
$16.7M Buy
264,052
+13,414
+5% +$868K 0.41% 60
2016
Q2
$15.5M Buy
250,638
+3,662
+1% +$223K 0.41% 63
2016
Q1
$14.1M Sell
246,976
-28,939
-10% -$1.61M 0.38% 64
2015
Q4
$16.3M Sell
275,915
-3,865
-1% -$223K 0.47% 57
2015
Q3
$15.2M Buy
279,780
+38,148
+16% +$2.48M 0.48% 53
2015
Q2
$16.2M Buy
241,632
+7,307
+3% +$477K 0.5% 48
2015
Q1
$13.7M Sell
234,325
-13,513
-5% -$816K 0.41% 60
2014
Q4
$16.3M Sell
247,838
-33,832
-12% -$2.13M 0.5% 46
2014
Q3
$16.3M Sell
281,670
-27,869
-9% -$1.55M 0.49% 46
2014
Q2
$17.5M Sell
309,539
-1,408
-0.5% -$73.9K 0.45% 50
2014
Q1
$16M Buy
310,947
+18,223
+6% +$921K 0.43% 53
2013
Q4
$15.3M Sell
292,724
-72,222
-20% -$3.55M 0.44% 47
2013
Q3
$16.3M Buy
364,946
+20,946
+6% +$928K 0.43% 52
2013
Q2
$14.2M Buy
+344,000
New +$15M 0.4% 51

Other funds holding ABBV

Mitsubishi UFJ Asset Management's ABBV Position: Q2 2026 in Review

Mitsubishi UFJ Asset Management increased its AbbVie (ABBV) stake by 7.7% in Q2 2026, buying an estimated $66.6M and bringing the position to 4,340,720 shares worth $1.09B. The position accounts for 0.61% of the portfolio, ranked #29.

Mitsubishi UFJ Asset Management first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 4,187 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Mitsubishi UFJ Asset Management held 4,340,720 shares of AbbVie worth $1.09B as of Q2 2026.
  • Mitsubishi UFJ Asset Management bought 309,681 AbbVie shares in Q2 2026, an estimated $66.6M.
  • AbbVie made up 0.61% of Mitsubishi UFJ Asset Management's portfolio in Q2 2026, its #29 holding.
  • Mitsubishi UFJ Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • 4,187 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.